Why Novavax Stock Should Soar Even Higher

Which stock was the biggest winner among COVID-19 vaccine makers in 2020? Pat yourself on the back if your answer was Novavax (NASDAQ: NVAX). Its shares skyrocketed a whopping 2,700%. This year is off to a roaring start for the biotech stock as well. Novavax's shares are up close to 140%.

Hot stocks can get too hot, though. Some might think that's the case for Novavax. But I don't. Here are three reasons why Novavax stock should soar even higher.

Image source: Getty Images.

Continue reading


Source Fool.com